Cocrystal Pharma Inc (COCP)
1.825
+0.10
(+5.49%)
USD |
NASDAQ |
Oct 04, 16:00
1.85
+0.02
(+1.37%)
After-Hours: 20:00
Cocrystal Pharma Shareholders Equity (Annual): 26.38M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 26.38M |
| December 31, 2022 | 39.57M |
| December 31, 2021 | 77.55M |
| December 31, 2020 | 52.50M |
| December 31, 2019 | 25.71M |
| December 31, 2018 | 66.89M |
| December 31, 2017 | 105.40M |
| December 31, 2016 | 102.32M |
| December 31, 2015 | 167.59M |
| Date | Value |
|---|---|
| December 31, 2014 | 6.651M |
| December 31, 2013 | -8.833M |
| December 31, 2012 | -3.580M |
| December 31, 2011 | -2.769M |
| December 31, 2010 | -0.5892M |
| December 31, 2009 | 0.0571M |
| December 31, 2008 | 0.0967M |
| December 31, 2007 | 0.1478M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
25.71M
Minimum
2019
77.55M
Maximum
2021
44.34M
Average
39.57M
Median
2022
Shareholders Equity (Annual) Benchmarks
| Perspective Therapeutics Inc | 75.18M |
| Alaunos Therapeutics Inc | 6.307M |
| Oragenics Inc | 3.168M |
| Cara Therapeutics Inc | 57.08M |
| Jaguar Health Inc | 4.961M |